The role of peripheral Na plus channels in triggering the central excitatory effects of intravenous cocaine

被引:13
作者
Brown, P. Leon [1 ]
Kiyatkin, Eugene A. [1 ]
机构
[1] Natl Inst Drug Abuse, Cellular Neurobiol Branch, Intramural Res Program, DHHS,NIH, Baltimore, MD 21224 USA
关键词
behavior; brain temperature; cocaine methiodide; dopamine uptake inhibition; metabolic brain activation; procaine; rats;
D O I
10.1111/j.1460-9568.2006.05001.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While alterations in dopamine (DA) uptake appear to be a critical mechanism underlying locomotor and reinforcing effects of cocaine (COC), many centrally mediated physiological and affective effects of this drug are resistant to DA receptor blockade and are expressed more quickly following an intravenous (i.v.) injection than expected based on the dynamics of drug concentration in the brain. Because COC is also a potent local anesthetic, its rapid action on Na+ channels may be responsible for triggering these effects. We monitored temperatures in the nucleus accumbens, temporal muscle and skin together with conventional locomotion during a single i.v. injection of COC (1 mg/kg), procaine (PRO, 5 mg/kg; equipotential anesthetic dose), a short-acting local anesthetic drug that, like COC, interacts with Na+ channels, and cocaine methiodide (COC-MET, 1.31 mg/kg, equimolar dose), a quaternary COC derivative that is unable to cross the blood-brain barrier. In this way, we explored not only the importance of Na+ channels in general, but also the importance of central vs. peripheral Na+ channels specifically. COC induced locomotor activation, temperature increase in the brain and muscle, and a biphasic temperature fluctuation in skin. Though PRO did not induce locomotor activation, it mimicked, to a greater degree, the temperature effects of COC. Therefore, Na+ channels appear to be a key substrate for COC-induced temperature fluctuations in the brain and periphery. Similar to PRO, COC-MET had minimal effects on locomotion, but mimicked COC in its ability to increase brain and muscle temperature, and induce transient skin hypothermia. It appears therefore that COC's interaction with peripherally located Na+ channels triggers its central excitatory effects manifested by brain temperature increase, thereby playing a major role in drug sensing and possibly contributing to COC reinforcement.
引用
收藏
页码:1182 / 1192
页数:11
相关论文
共 68 条
[1]   THE EFFECTS OF PROCAINE HCL ON POPULATION CELLULAR AND EVOKED-RESPONSE ACTIVITY WITHIN THE LIMBIC SYSTEM OF THE CAT - EVIDENCE FOR DIFFERENTIAL EXCITATORY ACTION OF PROCAINE IN A VARIETY OF LIMBIC CIRCUITS [J].
ADAMEC, RE ;
STARKADAMEC, C .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1987, 11 (04) :345-364
[2]   Cocaine-like effects of intravenous procaine in cocaine addicts [J].
Adinoff, B ;
Brady, K ;
Sonne, S ;
Mirabella, RE ;
Kellner, CH .
ADDICTION BIOLOGY, 1998, 3 (02) :189-196
[3]   VARIABILITY OF SKIN TEMPERATURE IN WALKING MONKEY [J].
BAKER, MA ;
CRONIN, MJ ;
MOUNTJOY, DG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1976, 230 (02) :449-455
[4]   Acute effects of cocaine on human brain activity and emotion [J].
Breiter, HC ;
Gollub, RL ;
Weisskoff, RM ;
Kennedy, DN ;
Makris, N ;
Berke, JD ;
Goodman, JM ;
Kantor, HL ;
Gastfriend, DR ;
Riorden, JP ;
Mathew, RT ;
Rosen, BR ;
Hyman, SE .
NEURON, 1997, 19 (03) :591-611
[5]  
Catterall W, 1996, GOODMAN GILMANS PHAR, P331
[6]  
CHAIT LD, 1993, J PHARMACOL EXP THER, V267, P296
[7]   Mechanism of cocaine-induced hyperthermia in humans [J].
Crandall, CG ;
Vongpatanasin, W ;
Victor, RG .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (11) :785-791
[8]  
CREVELING CR, 1983, MOL PHARMACOL, V23, P350
[9]   INTRACEREBRAL TEMPERATURES IN FREE-MOVING CATS [J].
DELGADO, JMR ;
HANAI, T .
AMERICAN JOURNAL OF PHYSIOLOGY, 1966, 211 (03) :755-+
[10]   Cocaine-induced cardiovascular effects: Lack of evidence for a central nervous system site of action based on hemodynamic studies with cocaine methiodide [J].
Dickerson, LW ;
Rodak, DJ ;
Kuhn, FE ;
Wahlstrom, SK ;
Tessel, RE ;
Visner, MS ;
Schaer, GL ;
Gillis, RA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (01) :36-42